SCHEMBL24246717

SCHEMBL24246717

O=C1NN=C(c2ccccc2)c2ccccc2N1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.55
GABRG2 P18507 1/20 0.55
GABRB3 P28472 1/20 0.55
GABRA5 P31644 1/20 0.55
GABRA3 P34903 1/20 0.55
GABRA2 P47869 1/20 0.55
GABRB2 P47870 1/20 0.55
LMNA P02545 4/20 0.46
MAPT P10636 2/20 0.46
CHRM1 P11229 1/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CCNE2 O96020 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
CCKBR P32239 8/20 0.42
CCKAR P32238 3/20 0.42
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8319461 0.87 BRD4 (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24457588 0.77 ALDH1A1 (0.49) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL4714384 0.72 GABRA1 (0.55) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL9524748 0.72 MEN1 (0.71) LMNACHRM1ALDH1A1MEN1KMT2A
SCHEMBL9524753 0.72 MEN1 (0.71) LMNACHRM1ALDH1A1MEN1KMT2A
Ro-052921 SCHEMBL29979594 0.71 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA5GABRA3
Ro-052921 SCHEMBL1365706 0.71 GABRA1 (1.00) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL4790341 0.71 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL5803308 0.70 GABRA1 (0.53) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6255304 0.70 LRRK2 (0.58) LMNAMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247973-B2 Antiviral benzodiazepine compounds THE UNIVERSITY OF DURHAM (GB) 2022-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247973-B2 Antiviral benzodiazepine compounds GABRA5, GABRA1, GABRA6 GABRA1 2/4885GABRG2 18/4885GABRB3 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.